发明名称 |
Implantable device for long-term delivery of drugs |
摘要 |
A device for sustained delivery of a poorly water soluble drug is described. A drug reservoir within the device, when in operation, contains an aqueous suspension of the drug mixed with a suspension of an excipient that, in one embodiment, generates acidic groups for a sustained period of time to maintain a desired pH in the aqueous suspension that in turn provides a constant concentration of a soluble form of the drug. |
申请公布号 |
US9561352(B2) |
申请公布日期 |
2017.02.07 |
申请号 |
US201012918369 |
申请日期 |
2010.03.11 |
申请人 |
Delpor, Inc. |
发明人 |
Martin Francis J.;Kang Ling-Ling |
分类号 |
A61M31/00;A61K9/00;A61K31/505;A61K47/34;A61M37/00 |
主分类号 |
A61M31/00 |
代理机构 |
McDermott Will & Emery LLP |
代理人 |
Mohr Judy M.;McDermott Will & Emery LLP |
主权项 |
1. A drug delivery device, comprising:
a non-erodible, non-porous housing member defining a reservoir, said housing member having a water impermeable outer surface and first and second opposing ends; a porous partition positioned in the first end of the housing member; contained within said reservoir, a drug formulation comprised of a sparingly water soluble drug and a solubility-modifying excipient, said sparingly water soluble drug having a soluble form and an insoluble form, wherein the insoluble form of the drug is retained in the reservoir, and wherein said solubility-modifying excipient is capable of generating acid groups to provide a concentration of the drug, in an aqueous suspension when the drug formulation is hydrated, to provide release of a therapeutic dose of the drug from the device over a period of between about 2-12 months, as the soluble form of the drug freely diffuses out of the device across said partition; and wherein release of the therapeutic dose is dependent on pH of the drug formulation and independent of pore size of the porous partition. |
地址 |
San Francisco CA US |